MGI Enters Strategic Partnership with Prepaire Labs

Dubai, UAE, 5 February 2024 - MGI, a company committed to building core tools and technology to lead life science, today announced its collaboration with Prepaire Labs at MEDLAB Middle East 2024 to further empower precision medicine. The collaboration, includes MGI's first corporate order of the revolutionary DNBSEQ-T20à—2 ("T20") ultra-high throughput sequencer in the Middle East and the first application of the company's sequencing technology in drug discovery in the region. Image Credit: MGI "We are thrilled to work with Prepaire Labs to harness T20's ultra-high throughput and great cost-efficiency for understanding and treating diseases at a personalized level," said…